Universal antenatal screening for group B streptococcus may cause more harm than good
- 20 February 2019
- Vol. 364, l463
- https://doi.org/10.1136/bmj.l463
Abstract
Based on current evidence, routine screening for group B streptococcus colonisation in late pregnancy should not be introduced in the UK, as the potential harms of unnecessary treatment with antibiotics may outweigh the benefits, argue Farah Seedat and colleaguesKeywords
This publication has 71 references indexed in Scilit:
- An overview of global GBS epidemiologyVaccine, 2013
- Screening pregnant women for group B streptococcus infection between 30 and 32 weeks of pregnancy in a population at high risk for premature birthInternational Journal of Gynecology & Obstetrics, 2013
- The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008The Pediatric Infectious Disease Journal, 2011
- Group B Streptococcus Early-Onset Disease in Emilia-Romagna: Review After Introduction of a Screening-Based ApproachThe Pediatric Infectious Disease Journal, 2010
- Institution of universal screening for Group B streptococcus (GBS) from a risk management protocol results in reduction of early‐onset GBS disease in a tertiary obstetric unitAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2007
- HypothesisThe Pediatric Infectious Disease Journal, 2006
- Use of Intrapartum Antibiotics and the Incidence of Postnatal Maternal and Neonatal Yeast InfectionsObstetrics & Gynecology, 2005
- Beyond ScreeningThe Pediatric Infectious Disease Journal, 2005
- Effects of Intrapartum Penicillin Prophylaxis on Intestinal Bacterial Colonization in InfantsJournal of Clinical Microbiology, 2004
- A randomized, prospective study of adjunctive ceftizoxime in preterm laborAmerican Journal of Obstetrics and Gynecology, 1995